Levy Raphi 4

What Happened

• Levy Raphi, Chief Financial Officer of Alpha Tau Medical Ltd. (DRTS), sold a total of 32,500 shares in two transactions on 2026-06-03. He disposed of 17,500 shares at $10.90 (reported $190,759) and 15,000 shares at $10.76 (reported $161,357), for a combined reported proceeds of about $352,116 (~$10.83 average price). These were reported as sales (code S), described as open-market/private-sale transactions. Sales are often routine insider liquidity events and do not by themselves indicate company outlook.

Key Details

• Transaction dates and prices: 2026-06-03 — 17,500 @ $10.90 ($190,759 reported); 15,000 @ $10.76 ($161,357 reported).
• Total shares sold: 32,500; total reported proceeds: $352,116 (approximate average price $10.83).
• Transaction type/code: Sale (S) — reported as open-market/private sale.
• Shares owned after transaction: Not specified in the details provided in this summary (refer to the full Form 4 for post-transaction holdings).
• Filing date and timeliness: Form filed 2026-06-04 for trades on 2026-06-03 (filed the next day; not flagged as late).
• No 10b5-1 plan, tax-withholding, gift, or option-exercise footnotes were indicated in the transaction details provided here.

Context

• Sales by executives can be for many personal reasons (diversification, taxes, cash needs) and are more common than purchases; purchases tend to be considered a stronger bullish signal. This summary is factual and does not infer motive. For full holdings, footnotes, and exact post-transaction ownership, consult the complete Form 4 (Accession 0001213900-26-065201).